Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

A disruptive hypoxia activated prodrug for the treatment of resistant cancers: an AI-driven approach

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Intellectual Property Rights

KINASE INHIBITOR PRODRUG FOR THE TREATMENT OF CANCER

Application/Publication number: 15 865257
Date: 2015-12-03
Applicant(s): CONVERT PHARMACEUTICALS

PRODRUGS AND MEDICAL USES THEREOF

Application/Publication number: 20 19064112
Date: 2019-05-29
Applicant(s): CONVERT PHARMACEUTICALS

NOVEL PRODRUGS AND METHODS OF USE THEREOF

Application/Publication number: 13 831349
Date: 2013-08-22
Applicant(s): CONVERT PHARMACEUTICALS

PRODRUG FORMS OF KINASE INHIBITORS AND THEIR USE IN THERAPY

Application/Publication number: 10 751067
Date: 2010-03-11
Applicant(s): CONVERT PHARMACEUTICALS

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0